Skip to content

SCCOR Minorities Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02898272
Enrollment
40
Registered
2016-09-13
Start date
2016-08-31
Completion date
2023-03-31
Last updated
2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emphysema, Pulmonary Disease, Chronic Obstructive

Brief summary

The SCCOR Minorities study will recruit minority participants from the COPDGene cohort, in whom the University of Pittsburgh has already obtained baseline and five year data, in order to enhance bone mineral density and vascular function data collection from minority smokers. Dual X-ray absorptiometry (DXA) scans will be obtained to measure bone mineral density. Non-invasive vascular studies will be performed to measure endothelial function. Questionnaires regarding symptoms and activity levels will be administered and a blood sample will be obtained in participants in which blood samples are not already available from the COPDGene study visits.

Interventions

None listed

Sponsors

University of Pittsburgh
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* African American male and female subjects participating in COPDGene study

Exclusion criteria

* caucasians * pregnant women

Design outcomes

Primary

MeasureTime frame
Dual Xray Absorptiometry measurement of lumbar spine and hip bone mineral density.As this is a cross-sectional collection of data, the outcome will be measured once at the first and only study visit.

Secondary

MeasureTime frame
Measurement of carotid artery intimal thickness with ultrasoundAs this is a cross-sectional collection of data, the outcome will be measured once at the first and only study visit.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026